Emerald Mutual Fund Advisers Trust Revolution Medicines, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2020 Jul 28, 2020	SELL	$19.65 - $39.34 $902,288 - $1.81 Million	-45,918 Closed	0 $0
Q1 2020 Apr 30, 2020	BUY	$20.0 - $34.08 $918,360 - $1.56 Million	45,918 New	45,918 $1.01 Million

280

162M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.7B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.